S
Skin Physicians Dermatology | Edmonton, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Lebrikizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic d...
Enrolling
Atopic Dermatitis
Drug: Lebrikizumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems